DE69433221D1 - Neues Chondrozytprotein - Google Patents

Neues Chondrozytprotein

Info

Publication number
DE69433221D1
DE69433221D1 DE69433221T DE69433221T DE69433221D1 DE 69433221 D1 DE69433221 D1 DE 69433221D1 DE 69433221 T DE69433221 T DE 69433221T DE 69433221 T DE69433221 T DE 69433221T DE 69433221 D1 DE69433221 D1 DE 69433221D1
Authority
DE
Germany
Prior art keywords
chondrocytes
protein
cartilaginous
control
found
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433221T
Other languages
English (en)
Other versions
DE69433221T2 (de
Inventor
Yukio Kato
Haiou Pan
Kazuyuki Doi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69433221D1 publication Critical patent/DE69433221D1/de
Publication of DE69433221T2 publication Critical patent/DE69433221T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69433221T 1993-07-23 1994-07-19 Neues Chondrozytprotein Expired - Fee Related DE69433221T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18233893 1993-07-23
JP18233893 1993-07-23

Publications (2)

Publication Number Publication Date
DE69433221D1 true DE69433221D1 (de) 2003-11-13
DE69433221T2 DE69433221T2 (de) 2004-07-29

Family

ID=16116566

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433221T Expired - Fee Related DE69433221T2 (de) 1993-07-23 1994-07-19 Neues Chondrozytprotein

Country Status (7)

Country Link
US (1) US5607920A (de)
EP (1) EP0635518B1 (de)
KR (1) KR950003312A (de)
AT (1) ATE251640T1 (de)
AU (1) AU687407B2 (de)
CA (1) CA2128647A1 (de)
DE (1) DE69433221T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858689A (en) * 1993-07-22 1999-01-12 Ludwig Institute For Cancer Research Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
US6008013A (en) * 1996-07-05 1999-12-28 University Of Rochester Chondrocyte proteins
US6312952B1 (en) 1999-05-27 2001-11-06 The Research Foundation Of State University Of New York In vitro cell culture device including cartilage and methods of using the same
EP1219303A4 (de) * 1999-08-19 2003-05-07 Chugai Pharmaceutical Co Ltd Promotoren der chondrogenese
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
JPH05178896A (ja) * 1990-08-23 1993-07-20 Mitsubishi Kasei Corp 新規なタンパク質、それをコードする遺伝子及びその産生方法

Also Published As

Publication number Publication date
AU687407B2 (en) 1998-02-26
US5607920A (en) 1997-03-04
EP0635518B1 (de) 2003-10-08
EP0635518A1 (de) 1995-01-25
AU6860294A (en) 1995-02-02
DE69433221T2 (de) 2004-07-29
ATE251640T1 (de) 2003-10-15
KR950003312A (ko) 1995-02-16
CA2128647A1 (en) 1995-01-24

Similar Documents

Publication Publication Date Title
BR1100321A (pt) Polipetìdeo utilizável como elemento de imunogenia, agente imunogênio, composição útil para a prevenção e/ou para o tratamento das afecções provocadas pelo vrs, sequência nucleotìdica, processo de pre uma proteìna
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
ES2160704T3 (es) Tratamiento del sindrome de insensibilidad parcial a la hormona de crecimiento.
LU90855I2 (en) Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables
MY102806A (en) Human interleukin-3 and muteins thereof
DE69022297T2 (de) DNS und ihre Verwendung.
ATE404668T1 (de) Wachstumsfaktor-homologe zvegf-3
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
PH27403A (en) Polypeptides useful as lockers of calcium channel
HU895788D0 (en) Process for producing peptides and medical products containing them
ATE251640T1 (de) Neues chondrozytprotein
EP0515434A4 (en) Method for treating intestinal diseases
ATE366310T1 (de) Menschliches chondromodulin-i-protein
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
PT914148E (pt) Tratamento do sindroma de insensibilidade parcial a hormona de crescimento
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
ES2129022T3 (es) Proteina condromodulina-i.
MX9800686A (es) Nueva proteina hmw humana mp52s.
EP0903147A3 (de) Verwendung eines REG-2 als Mitogene für Schwannzellen
CA2129919A1 (en) Pharmaceutical Composition Having Antiviral and Antibacterial Activity and Method of Administration
ATE127018T1 (de) Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee